-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
KalVista Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2023.
- KalVista Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending July 31, 2024 was $3.77M, a 0.11% decline year-over-year.
- KalVista Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending July 31, 2024 was $13.8M, a 25.3% decline year-over-year.
- KalVista Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $13.8M, a 23.2% decline from 2022.
- KalVista Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $18M, a 25.9% increase from 2021.
- KalVista Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $14.3M, a 22.2% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)